🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05621460
Recruiting Not applicable

The Effect of Water Carbonation on Orthostatic Tolerance

NCT05621460 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2023-09-01
Last updated
2026-04-23

Condition(s) studied

Orthostatic HypotensionSyncopeVasovagal Syncope

Investigational drug(s) / intervention(s)

500mL carbonated water500mL still water50mL still water

500mL carbonated water: Drink 500mL carbonated water immediately prior to head-up tilt test

500mL still water: Drink 500mL still water immediately prior to head-up tilt test

50mL still water: Drink 50mL still water immediately prior to head-up tilt test

Study summary

The primary purpose of this investigation is to determine whether water carbonation can improve orthostatic tolerance in healthy control volunteers. Orthostatic tolerance refers to the ability to maintain an adequate blood pressure when standing. In some individuals blood pressure can fall when standing, predisposing to dizzy spells or fainting episodes. Drinking water can boost blood pressure and making fainting episodes less likely. However, it is not clear whether the carbonation of the water has any further impact on the blood pressure response. This is important because it may be that carbonated water expands the stomach (gastric distension), provoking an increase in sympathetic activity. The increase in sympathetic nervous system activity boosts blood pressure. Resolving this question would have important implications for patients with syncope. This study will test whether carbonated water will have any further impact on blood pressure than the already known effect of non-carbonated water.

Eligibility

Sex
ALL
Min age
19 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * healthy, English-speaking Exclusion Criteria: * pregnancy or suspected pregnancy, history of cardiovascular disease, history of neurological disease, history of recurrent fainting (≥ 2 episodes of fainting with loss of consciousness in the prior 6 months)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Simon Fraser University Burnaby British Columbia Recruiting

More Simon Fraser University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05621460 on ClinicalTrials.gov ↗ ← All trials in Canada